BIMI International Medical Inc.
BIMI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $2 | $3 |
| - Cash | $2 | $5 | $0 | $0 |
| + Debt | $5 | $9 | $5 | $0 |
| Enterprise Value | $3 | $5 | $7 | $3 |
| Revenue | $12 | $21 | $13 | $0 |
| % Growth | -44.5% | 66% | 8,030.9% | – |
| Gross Profit | $2 | $2 | $2 | -$0 |
| % Margin | 16.5% | 11.4% | 19% | -92.4% |
| EBITDA | -$18 | -$32 | -$3 | -$1 |
| % Margin | -151.9% | -150% | -25% | -802.7% |
| Net Income | -$22 | -$35 | -$5 | -$4 |
| % Margin | -189.3% | -164.1% | -41.2% | -2,809.9% |
| EPS Diluted | -8.4 | -65.1 | -24.8 | -27.5 |
| % Growth | 87.1% | -162.5% | 9.8% | – |
| Operating Cash Flow | -$10 | -$1 | -$4 | -$2 |
| Capital Expenditures | $0 | -$1 | -$0 | $0 |
| Free Cash Flow | -$10 | -$2 | -$4 | -$2 |